<p>In A, B and C, effects of levosimendan on p-Bax, p-Caspase 9 and Caspase 8, respectively. Densitometric analysis and an example of lanes taken in one of 5 different experiments performed for each experimental protocol are reported. Abbreviations are as in Figs <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124742#pone.0124742.g001" target="_blank">1</a>–<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0124742#pone.0124742.g005" target="_blank">5</a>. b, c, d, e, f, g <i>P</i> <0.05 vs a; c, d, e, f, g <i>P</i> <0.05 vs b; d, e <i>P</i> <0.05 vs c; d, f, g <i>P</i> <0.05 vs e. The results of densitometric analysis are expressed as means of 5 independent experiments (%) ± SD (indicated by the ba...
Objective To ascertain if levosimendan postconditioning can alleviate lung ischemia–reperfusion inju...
<p><b>A)</b> Effect of levo on cAMP. <b>B)</b> Effect of levo on cGMP. <b>C)</b> Effect of levo on N...
channels. The aim of this study was to examine possible protective effects of levosimendan in a rat...
<p>In A, B and C, effects of levosimendan on p-Bax, LC3I/II and p-Akt, respectively. Densitometric a...
<p>In A and B, effects of levosimendan on p-Akt and p-ERK1/2, respectively. Densitometric analysis a...
<p>In A and B, effects of levosimendan on Beclin 1 and LC3I/II, respectively. Densitometric analysis...
<p>In A and B, densitometric analysis of p-eNOS and iNOS and an example of lanes taken in one of 5 d...
<p>C = control; Levo = levosimendan; ZVAD = Z-VAD.FMK (Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromet...
<p>In A and B, b, c, d, e, f, g <i>P</i> <0.05 vs a; c, d, e, f, g <i>P</i> <0.05 vs b; d, e <i>P</i...
<p>In A, hepatocytes in physiological condition. b, c, d <i>P</i> <0.05 vs a; c, d <i>P</i> <0.05 vs...
<p>In A and B, b, c, e, f, g <i>P</i><0.05 vs a; c, d, e, f, g <i>P</i><0.05 vs b; d, e <i>P</i><0.0...
<p>Data are means (%) ± SD of 5 independent experiments. C: control; L = levosimendan (1 μM); Z-VAD ...
Background Levosimendan protects rat liver against peroxidative injuries through mechanisms related ...
BACKGROUND: Levosimendan protects rat liver against peroxidative injuries through mechanisms rela...
. channels inhibition and NOS blocking. In HSC, levosimendan was able to modulate the oxidative bala...
Objective To ascertain if levosimendan postconditioning can alleviate lung ischemia–reperfusion inju...
<p><b>A)</b> Effect of levo on cAMP. <b>B)</b> Effect of levo on cGMP. <b>C)</b> Effect of levo on N...
channels. The aim of this study was to examine possible protective effects of levosimendan in a rat...
<p>In A, B and C, effects of levosimendan on p-Bax, LC3I/II and p-Akt, respectively. Densitometric a...
<p>In A and B, effects of levosimendan on p-Akt and p-ERK1/2, respectively. Densitometric analysis a...
<p>In A and B, effects of levosimendan on Beclin 1 and LC3I/II, respectively. Densitometric analysis...
<p>In A and B, densitometric analysis of p-eNOS and iNOS and an example of lanes taken in one of 5 d...
<p>C = control; Levo = levosimendan; ZVAD = Z-VAD.FMK (Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromet...
<p>In A and B, b, c, d, e, f, g <i>P</i> <0.05 vs a; c, d, e, f, g <i>P</i> <0.05 vs b; d, e <i>P</i...
<p>In A, hepatocytes in physiological condition. b, c, d <i>P</i> <0.05 vs a; c, d <i>P</i> <0.05 vs...
<p>In A and B, b, c, e, f, g <i>P</i><0.05 vs a; c, d, e, f, g <i>P</i><0.05 vs b; d, e <i>P</i><0.0...
<p>Data are means (%) ± SD of 5 independent experiments. C: control; L = levosimendan (1 μM); Z-VAD ...
Background Levosimendan protects rat liver against peroxidative injuries through mechanisms related ...
BACKGROUND: Levosimendan protects rat liver against peroxidative injuries through mechanisms rela...
. channels inhibition and NOS blocking. In HSC, levosimendan was able to modulate the oxidative bala...
Objective To ascertain if levosimendan postconditioning can alleviate lung ischemia–reperfusion inju...
<p><b>A)</b> Effect of levo on cAMP. <b>B)</b> Effect of levo on cGMP. <b>C)</b> Effect of levo on N...
channels. The aim of this study was to examine possible protective effects of levosimendan in a rat...